Illumina Inc. (ILMN): Price and Financial Metrics


Illumina Inc. (ILMN): $183.06

-3.37 (-1.81%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ILMN to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

ILMN POWR Grades


  • ILMN scores best on the Sentiment dimension, with a Sentiment rank ahead of 75.68% of US stocks.
  • The strongest trend for ILMN is in Momentum, which has been heading down over the past 179 days.
  • ILMN ranks lowest in Growth; there it ranks in the 9th percentile.

ILMN Stock Summary

  • Illumina Inc's market capitalization of $56,103,950,000 is ahead of 95.16% of US-listed equities.
  • ILMN's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,665.82 -- higher than 98.16% of US-listed equities with positive expected earnings growth.
  • Price to trailing twelve month operating cash flow for ILMN is currently 102.94, higher than 95.69% of US stocks with positive operating cash flow.
  • Stocks that are quantitatively similar to ILMN, based on their financial statements, market capitalization, and price volatility, are CRWD, SPLK, FICO, TWLO, and GH.
  • Visit ILMN's SEC page to see the company's official filings. To visit the company's web site, go to www.illumina.com.

ILMN Valuation Summary

  • In comparison to the median Healthcare stock, ILMN's EV/EBIT ratio is 133.79% higher, now standing at 68.5.
  • Over the past 243 months, ILMN's price/sales ratio has gone down 111.2.
  • ILMN's price/sales ratio has moved down 111.2 over the prior 243 months.

Below are key valuation metrics over time for ILMN.

Stock Date P/S P/B P/E EV/EBIT
ILMN 2021-08-31 16.9 12.9 87.3 68.5
ILMN 2021-08-30 16.9 12.9 87.3 68.5
ILMN 2021-08-27 17.2 13.2 88.7 69.7
ILMN 2021-08-26 17.4 13.3 89.9 70.7
ILMN 2021-08-25 18.0 13.8 93.1 73.2
ILMN 2021-08-24 17.7 13.6 91.6 72.0

ILMN Growth Metrics

    The 5 year price growth rate now stands at 115.77%.
  • Its 3 year net income to common stockholders growth rate is now at 105.31%.
  • The 5 year net income to common stockholders growth rate now stands at 127.27%.
Over the past 34 months, ILMN's revenue has gone up $1,130,000,000.

The table below shows ILMN's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 4,526 545 762
2021-09-30 4,280 669 906
2021-06-30 3,966 1,094 768
2021-03-31 3,473 1,081 630
2020-12-31 3,239 1,080 656
2020-09-30 3,238 1,117 638

ILMN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ILMN has a Quality Grade of B, ranking ahead of 94.64% of graded US stocks.
  • ILMN's asset turnover comes in at 0.489 -- ranking 48th of 75 Measuring and Control Equipment stocks.
  • AMOT, AATC, and TRMB are the stocks whose asset turnover ratios are most correlated with ILMN.

The table below shows ILMN's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-07-04 0.489 0.686 0.187
2021-04-04 0.448 0.676 0.175
2021-01-03 0.439 0.680 0.173
2020-09-27 0.443 0.690 0.165
2020-06-28 0.464 0.703 0.174
2020-03-29 0.497 0.704 0.209

ILMN Price Target

For more insight on analysts targets of ILMN, see our ILMN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $459.00 Average Broker Recommendation 1.92 (Hold)

ILMN Stock Price Chart Interactive Chart >

Price chart for ILMN

ILMN Price/Volume Stats

Current price $183.06 52-week high $526.00
Prev. close $186.43 52-week low $180.00
Day low $181.17 Volume 214,052
Day high $186.62 Avg. volume 1,153,744
50-day MA $240.74 Dividend yield N/A
200-day MA $339.51 Market Cap 28.76B

Illumina Inc. (ILMN) Company Bio


Illumina, Inc. is an American company. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencinggenotyping and gene expression, and proteomics markets. Its headquarters are located in San Diego, California. (Source:Wikipedia)


ILMN Latest News Stream


Event/Time News Detail
Loading, please wait...

ILMN Latest Social Stream


Loading social stream, please wait...

View Full ILMN Social Stream

Latest ILMN News From Around the Web

Below are the latest news stories about Illumina Inc that investors may wish to consider to help them evaluate ILMN as an investment opportunity.

“The World Expands”: Celebrating Rare Disease Day in Japan

Through an organization called ASrid, patient families find connection and hope

Yahoo | February 24, 2022

Skis, Skincare, and More: Making Better Products With Algae

Materials innovation company Checkerspot is using microalgae to create a sustainable alternative to petroleum

Yahoo | February 22, 2022

Illumina To Webcast Upcoming Investor Conference

Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:

Yahoo | February 21, 2022

Global Laboratory Consumables Market Report, Featuring Profiles of Key Players Including Agilent, Beckman Coulter, Bio-Rad, PerkinElmer, Roche and Shimadzu

DUBLIN , Feb. 18, 2022 /PRNewswire/ -- The "Global Laboratory Consumables Market 2021" report has been added to ResearchAndMarkets.com''s offering. The Global Laboratory Consumables Market report is designed for general management, product managers and marketing executives in the laboratory consumables industry. For them, it provides up-to-date market data about those technologies in their areas of interest. and related markets. Information on specific segments or the whole industry can be used to evaluate markets, the competitive landscape, or identify opportunities and acquisition targets. A strategy for the consumables market must involve geographic market composition, market growth rate, and new competitors. This report saves time by providing comprehensive data in an easily readabl...

Benzinga | February 18, 2022

Top Research Reports for Merck, Shopify & Intercontinental Exchange

Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Shopify Inc. (SHOP), and Intercontinental Exchange, Inc. (ICE).

Yahoo | February 18, 2022

Read More 'ILMN' Stories Here

ILMN Price Returns

1-mo -23.56%
3-mo -49.69%
6-mo -51.88%
1-year -61.32%
3-year -50.61%
5-year 5.50%
YTD -51.88%
2021 2.82%
2020 11.53%
2019 10.61%
2018 37.27%
2017 70.64%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4725 seconds.